News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
407,750 Results
Type
Article (20899)
Company Profile (44)
Press Release (386803)
Multimedia
Podcasts (23)
Webinars (12)
Section
Business (126749)
Career Advice (449)
Deals (20900)
Drug Delivery (41)
Drug Development (39328)
Employer Resources (41)
FDA (12671)
Job Trends (8365)
News (190152)
Policy (20983)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 Genetown Standard (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (1424)
Academic (1)
Accelerated approval (31)
ADA (14)
Adcomms (2)
Allergies (124)
Alliances (30436)
ALS (90)
Alzheimer's disease (844)
Antibody-drug conjugate (ADC) (276)
Approvals (13293)
Artificial intelligence (423)
ASCO (167)
Autoimmune disease (166)
Automation (36)
Bankruptcy (179)
Best Places to Work (6476)
BIO (30)
BIOSECURE Act (7)
Biosimilars (157)
Biotechnology (30)
Bladder cancer (145)
Brain cancer (46)
Breast cancer (436)
Cancer (3639)
Cardiovascular disease (266)
Career advice (416)
Career pathing (9)
CAR-T (126)
CDC (12)
Celiac Disease (1)
Cell therapy (356)
Cervical cancer (43)
Clinical research (36060)
Collaboration (1285)
Company closure (1)
Compensation (903)
Complete response letters (35)
COVID-19 (1426)
CRISPR (50)
C-suite (664)
Cystic fibrosis (71)
Data (4995)
Decentralized trials (3)
Denatured (12)
Depression (82)
Dermatology (59)
Diabetes (353)
Diagnostics (5437)
Digital health (45)
Diversity (7)
Diversity, equity & inclusion (14)
Drug discovery (196)
Drug pricing (60)
Drug shortages (6)
Duchenne muscular dystrophy (128)
Earnings (45368)
Editorial (16)
Employer branding (6)
Employer resources (40)
Events (50217)
Executive appointments (633)
FDA (15597)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (11)
Frontotemporal dementia (12)
Funding (981)
Gene editing (93)
Generative AI (24)
Gene therapy (295)
GLP-1 (401)
Government (2782)
Grass and pollen (4)
Guidances (312)
Healthcare (10653)
Hematology (121)
HIV (50)
Huntington's disease (19)
IgA nephropathy (54)
Immunology and inflammation (70)
Immuno-oncology (44)
Indications (138)
Infectious disease (1603)
Inflammatory bowel disease (123)
Inflation Reduction Act (5)
Influenza (81)
Intellectual property (222)
Interviews (48)
IPO (9081)
IRA (11)
Job creations (2071)
Job search strategy (372)
JPM (21)
Kidney cancer (11)
Labor market (46)
Layoffs (203)
Leadership (8)
Legal (4959)
Liver cancer (58)
Longevity (15)
Lung cancer (531)
Lymphoma (304)
Machine learning (34)
Management (12)
Manufacturing (571)
Marketing (4)
MASH (110)
Medical device (13433)
Medtech (13578)
Mergers & acquisitions (12597)
Metabolic disorders (715)
mRNA (76)
Multiple sclerosis (120)
NASH (6)
Neurodegenerative disease (204)
Neuropsychiatric disorders (36)
Neuroscience (1631)
Neurotech (1)
NextGen: Class of 2026 (3438)
Non-profit (2392)
Now hiring (36)
Obesity (244)
Opinion (79)
Ovarian cancer (107)
Pain (153)
Pancreatic cancer (201)
Parkinson's disease (180)
Partnered (22)
Patents (457)
Patient recruitment (478)
Peanut (41)
People (32748)
Pharmaceutical (14)
Pharmacy benefit managers (20)
Phase 1 (10019)
Phase 2 (15494)
Phase 3 (13144)
Pipeline (6307)
Policy (89)
Postmarket research (1310)
Preclinical (3888)
Press Release (42)
Prostate cancer (215)
Psychedelics (9)
Radiopharmaceuticals (180)
Rare diseases (527)
Real estate (3331)
Recruiting (17)
Regulatory (16927)
Reports (27)
Research institute (1424)
Resumes & cover letters (54)
Rett syndrome (24)
RNA editing (8)
RSV (41)
Schizophrenia (91)
Series A (153)
Series B (114)
Service/supplier (2)
Sickle cell disease (53)
Special edition (7)
Spinal muscular atrophy (104)
Sponsored (23)
Startups (2151)
Stomach cancer (4)
Supply chain (78)
Tariffs (23)
The Weekly (11)
Vaccines (445)
Venture capital (38)
Weight loss (106)
Women's health (78)
Worklife (1)
Date
Today (53)
Last 7 days (237)
Last 30 days (1167)
Last 365 days (16766)
2026 (9397)
2025 (16436)
2024 (18949)
2023 (22498)
2022 (31161)
2021 (33319)
2020 (32404)
2019 (26431)
2018 (20346)
2017 (19740)
2016 (18990)
2015 (22417)
2014 (16896)
2013 (14199)
2012 (15360)
2011 (15908)
2010 (13814)
Location
Africa (411)
Alabama (35)
Alaska (4)
Arizona (182)
Arkansas (10)
Asia (34284)
Australia (5171)
California (7202)
Canada (2338)
China (1027)
Colorado (353)
Connecticut (355)
Delaware (235)
Europe (56300)
Florida (1124)
Georgia (219)
Hawaii (1)
Idaho (27)
Illinois (608)
India (82)
Indiana (426)
Iowa (18)
Japan (501)
Kansas (69)
Kentucky (30)
Louisiana (39)
Maine (54)
Maryland (885)
Massachusetts (4864)
Michigan (199)
Minnesota (493)
Mississippi (6)
Missouri (106)
Montana (19)
Nebraska (17)
Nevada (70)
New Hampshire (60)
New Jersey (2290)
New Mexico (17)
New York (2106)
North Carolina (1011)
North Dakota (7)
Northern California (3509)
Ohio (228)
Oklahoma (13)
Oregon (21)
Pennsylvania (1420)
Puerto Rico (23)
Rhode Island (33)
South America (606)
South Carolina (71)
Southern California (3040)
Tennessee (127)
Texas (1208)
United States (26291)
Utah (301)
Vermont (2)
Virginia (190)
Washington D.C. (40)
Washington State (474)
West Virginia (3)
Wisconsin (98)
Wyoming (1)
407,750 Results for "molecular devices ltd united kingdom".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom
June 11, 2026
·
4 min read
Press Releases
Skyhawk Therapeutics Announces Expansion of its Global Pivotal FALCON-HD Clinical Trial for SKY-0515 in Huntington’s Disease to the United States, Canada and the United Kingdom
July 14, 2026
·
4 min read
Press Releases
United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026
June 1, 2026
·
3 min read
Press Releases
Tenpoint Therapeutics Announces United Kingdom Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults
July 13, 2026
·
3 min read
Press Releases
Tenpoint Therapeutics Announces United Kingdom YUVEZZI™ Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults
July 13, 2026
·
4 min read
Press Releases
Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
May 18, 2026
·
4 min read
Press Releases
Nuvation Bio Announces Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated in the United Kingdom
June 29, 2026
·
12 min read
Drug Development
5 molecular glues that could stick—and the companies stuck in
Molecular glue degraders are gaining traction in the clinic as well as funding from Big Pharma, with their potential to treat previously “undruggable” cancers and immunological diseases. Here are five clinical programs worth keeping an eye on.
July 6, 2026
·
6 min read
·
Michael Gibney
Press Releases
Bial Launches KYNMOBI® (Apomorphine Hydrochloride) in the United Kingdom
January 7, 2026
·
8 min read
Press Releases
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
February 15, 2026
·
5 min read
1 of 40,775
Next
